These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11082743)

  • 1. Zipeprol (Zinolta) abuse among American adolescents in Korea: a discussion of the problem, clinical presentation, and treatment.
    Ritchie EC; Andress D; Yi S; Styles JR
    Mil Med; 1996 Jan; 161(1):11-2. PubMed ID: 11082743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic characteristics of zipeprol-associated deaths in Korea.
    Chung HS; Choi HK; Kim EM; Park MJ; Chung KH; Yoo YC
    Arch Pharm Res; 1998 Jun; 21(3):286-90. PubMed ID: 9875445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmortem distribution of zipeprol.
    Yoo Y; Chung H; Kim E; Kim M
    J Anal Toxicol; 1994; 18(4):213-6. PubMed ID: 7967542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overdosage of zipeprol, a non-opiod antitussive agent.
    Moroni C; Cerchiari EL; Gasparini M; Rota E
    Lancet; 1984 Jan; 1(8367):45. PubMed ID: 6140366
    [No Abstract]   [Full Text] [Related]  

  • 5. An unusual death by zipeprol overdose.
    Kintz P; Tracqui A; Potard D; Petit G; Mangin P
    Forensic Sci Int; 1994 Feb; 64(2-3):159-63. PubMed ID: 8175086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal zipeprol and dextromethorphan poisonings in Korea.
    Yoo Y; Chung H; Kim E; Kim M
    J Anal Toxicol; 1996; 20(3):155-8. PubMed ID: 8735195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal zipeprol intoxication.
    Kintz P; Cirimele V; Tracqui A; Mangin P
    Int J Legal Med; 1995; 107(5):267-8. PubMed ID: 7632605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal poisoning by zipeprol in drug addicts.
    Crippa O; Polettini A; Avato FM
    J Forensic Sci; 1990 Jul; 35(4):992-9. PubMed ID: 2391486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convulsions and cerebral oedema associated with zipeprol abuse.
    Perraro F; Beorchia A
    Lancet; 1984 Jan; 1(8367):45-6. PubMed ID: 6140367
    [No Abstract]   [Full Text] [Related]  

  • 10. GC-MS procedure for the analysis of zipeprol.
    Kintz P; Flesch F; Jaeger A; Mangin P
    J Pharm Biomed Anal; 1993; 11(4-5):335-8. PubMed ID: 8357869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Convulsions with 3 antitussive substituted derivatives of piperazine (zipeprol, eprazinone, eprozinol)].
    Merigot P; Garnier R; Efthymiou ML
    Ann Pediatr (Paris); 1985 Jun; 32(6):504-6, 511. PubMed ID: 4026148
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dangerous party drugs: A2 and cough medicines. Increasing interest among Swedish adolescents].
    Knudsen K; Hultén P; Sass M; Sallin K
    Lakartidningen; 2007 Sep 12-18; 104(37):2606-8. PubMed ID: 17970398
    [No Abstract]   [Full Text] [Related]  

  • 13. Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects.
    Janiri L; Mannelli P; Persico AM; Diodato S; Tempesta E
    Drug Alcohol Depend; 1991 Mar; 27(2):121-5. PubMed ID: 2055160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zipeprol: preclinical assessment of abuse potential.
    Acteo MD; Bowman E; Butelman E; Englis JA; Harrish L; Jacobson AE; Mattson MV; Medzihradsky F; Patrick G; Rowlett JK; Smith CB; Winger G; Woods JH; Woolverton WL
    Drug Alcohol Depend; 1996 Oct; 42(2):93-104. PubMed ID: 8889408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity.
    Rispat G; Burgi H; Cosnier D; Duchêne-Marullaz P; Streichenberger G
    Arzneimittelforschung; 1976 Apr; 26(4):523-30. PubMed ID: 8057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
    Cosnier D; Hache J; Labrid C; Rispat G
    Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of drug testing as an early warning programme: the experience of the Republic of Korea.
    Chung H
    Bull Narc; 2005; 57(1-2):231-48. PubMed ID: 21338024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Addiction to zipeprol].
    Marembert A; Morin D
    Presse Med; 1993 Mar; 22(11):550. PubMed ID: 8511083
    [No Abstract]   [Full Text] [Related]  

  • 19. [Addiction to zipeprol. Report of 2 cases].
    Silva H; Salvo J
    Rev Med Chil; 1993 Sep; 121(9):1029-31. PubMed ID: 8191152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The problem of the addictive capacity of zipeprol. Results of an experimental and clinical investigation].
    Moroni F; Mannaioni PF
    Recenti Prog Med; 1986; 77(7-8):333-8. PubMed ID: 3024271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.